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higher mean levels of each hormone by all assays (p<O.OOl for all). Results of all assays 
correlated closely (r values ranging between 0.902 and 0.975). The table shows the per- 
formance of optimal hormone values for diagnosis of HF (from receiver-operating-char- 
acteristic (ROC) analysis). In multivariate analysis hormones by any assay remained 
independently predictive of HF (p<O.OOl for all). Conclusions: BNP or N-BNP are useful 
in the diagnosis of HF in acutely dyspneic patients, providing additional power over clinl- 
cal and radiological data. Sensitivity was best with the Biosite BNP assay. Specificity and 
positive predictive value were greatest with N-BNP assays. 
1136-76 Pregnancy Associated Cardiomyopathy: Clinical Profile 
in 137 Patients Diagnosed in the United States 
Mohammed W. Akhter, Avraham Shotan. Afshan Hameed. Harpreet Singh, Salman 
Khan, Usman Ahsan. Muhammad T. Khan, Uri Elkayam, University of Southern 
California, Los Angeles, CA 
Background: Pregnancy associated cardiomyopathy (PACM) is an uncommon, but 
some times fatal form of heart failure. Because of the rarity of PACM and geographical 
differences in its presentation, the clinical profile of this condition has not been clearly 
defined. Methods: We reviewed records of 137 patients with PACM, either referred to 
our heart failure program or obtained by a national survey. Results: ClinIcal profile: Age- 
16-43 years (mean 30 * 6); Ethnic background-Caucasians 66%, Blacks 21%. Hispanics 
lo%, others 3%; Gravity-l-11 (mean 2.6 * 2.2); Index pregnancy-1st - 51%, 2nd - 20%, 
3rd - 20%, 4th - 12%, 5th or more - 17%; Duration of pregnancy-20-42 weeks (mean 36 
* 5); Mode of delivery-vaginal 50%. cesarean - 49%, abortion - 1%. Associated Condi- 
tions: There was a strong association between PACM and history of hypertension during 
pregnancy (56%), use of tocolytic therapy (29%) and twin pregnancy (31%) 
Left ventricular ejection fraction (LVEF): LVEF at time of diagnosis was 3Oi 12%. 43+ 
~ 15% at 6 months follow tip and 45+ 15% during last follow-up at an average of 26 
months. Normalization of LVEF (>50%) was observed in 54% of cases. This occured 
mostly within the 1st 6 months and was more likely in Caucasians, older patients (2 30 
1 
yrs), patients with gestational hypertension, and those with LVEF >30 % at diagnosis. 
Death. transplantatron and AICDs: Death was reported in 12 patients between delivery 
day and 9 years postpartum. 6 of these patients died suddenly. 5 patients had heart 
transplantation and 3 AICD implantation. Conclusion: 1. Pregnancy associated cardi- 
omyopathy in the US can occur at any age and in various ethnic groups. 2. PACM is 
related to 1st or 2nd pregnancy in almost 60% of cases. 3. There is a strong association 
between PACM and hypertension, use of tocolytic therapy and twin pregnancy. 4. Nor- 
malization of LVEF occurs in approximately half of the patients usually within first 6 
months postpartum. 5. Recovery of LV function is more likely in Caucasians, patients > 
30 years old, history of elevated blood pressure during pregnancy and EF >30% at time .= 
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of diagnosis. 
1136-77 A Three-Month Weight Decrease Independently 
Predicted Increased Risk of Mortality and Heart Failure 
Hospitalization but Decreased Risk of Recurrent 
Myocardial Infarction in Patients With Acute Myocardial 
Infarction Complicated by Cardiac Failure 
Linn A. Kennedy, Margaret James, Ronnie Willenheimer, Malmo University Hospital, 
Malmo, Sweden 
Background: The prognostic impact of body weight and weight change has been little 
examined in patients after acute myocardial infarction (AMI). 
Methods: In 5477 patients with AMI and clinical signs of heart failure (HF) and/or systolic 
lefl ventricular dysfunction and/or anterior Q-waves, we assessed baseline body mass 
index (bBMI), weight change at 3 months (3-m WC), and several baseline variables com- 
prising demographics, patient history physical examination, laboratory values and medi- 
cation. Median follow-up from 3 months was around 1,000 days. Patients were 
categorized into four groups according to bBMI. 3-m WC was defined as WC (+/-) z-0.1 
kg/bBMI-unit. The value of 3-m WC lo predict total mortality, cardiac death, HF hospital- 
ization, and recurrent AMI was tested in uni- and multivariate Cox propoRional hazards 
models. 
Results: 4541 patients had complete 3-m WC data. During follow-up there were 503 
deaths, 318 cardiac deaths, 286 HF hospitalizations and 351 recurrent AMls. In univari- 
ate analysrs, relative to stable weight, 3-m decreasing weight was significantly predictive 
of death (HR 1.473, 95% Cl 1,210-l ,794. p<O.OOOl), cardiac death (HR 1.401, 1.093. 
1.797. p=O.OOE), and HF hospitalization (HR 1.459, 1.122-1.897. p=O.O05). However, 
decreasing weight was borderline significantly protective of recurrent AMI (HR 0.788, 
0,604-l ,028, p=O.O79). 
In multivariate analysis, stratified for bBMl.group, adjustment was done for baseline 
covariates including age, sex, smoking, blood pressure, pulse rate, S-glucose, S-creati- 
nine, cholesterol, triglycerides, hemoglobin, and history of diabetes, hypercholester- 
olemia, and AMI, and in-hospital treatment with aspirin, betablockers, diuretics, statins, 
and thrombolytics. Relative to stable weight, 3-m weight decrease was independently 
predictive of increased rusk of mortality (p=O.O236) and HF hospitalization (p=O.O373), but 
of decreased risk of recurrent AMI (p=O.O452). 
Conclusion: In a high risk post AMI population a 3-m body weight decrease was indepen- 
dently predictive of increased risk of all cause mortality and HF hospitalization, but inde- 
pendently predictive of decreased risk of recurrent AMI, in this multivariate model. 
1136-78 Brain Natriuretic Peptide and N-Terminal Brain 
Natriuretic Peptide in the Diagnosis of Heart Failure in 
Patients With Acute Shortness of Breath 
John G. Lainchbuq. Timothy G. Yandle, Elizabeth Campbell, Mark Richards, 
Christchurch School of Medicme and Health Sciences, Christchurch, New Zealand 
Background: Plasma brain natriuretic peptide (BNP) is useful in differentiating heart fail- 
ure (HF) from other causes of dyspnea. The N-terminal component (N-BNP) has a longer 
half-life, and increases in HF are proportionately greater. Methods: In 205 acutely dysp- 
neic patients we assessed the utility of BNP and N-BNP (and compared local and corn- 
mercial assays) for the diagnosis of HF. BNP was assayed with a point of care test 
(Biosite Diagnostics, California) and two locally developed radioimmunoassays, one 
(“clinical BNP”) has a shori incubation time for more rapid results than the other 
(“research BNP”). N-BNP was analysed with a local (“local N-BNP”) and a commercial 
assay (Roche Diagnostics, Germany). HF diagnosis was adjudicated by two cardiolo- 
gists using all information except hormone assays. Results: HF patients (n=70) had 
Optimal 
Value 
Sensi Speci Positive Negative Area Accuracy 
tivity ficity Predictive Predictive Under 
V&e Value ROC 
Curve 
Biosite 204pg/ml 94 70 82 
BNP 
96 0.88 78 
Clinical 44pmollL 88 82 69 
BNP 
94 0.89 84 
Resear 33pmoliL 87 82 71 
ch 
BNP 
92 0.90 83 
Roche 329pmol/L 82 87 76 
N-BNP 
90 0.89 85 
Local 238pmol/L 83 89 79 91 0.91 87 
N-BNP 
1136-79 Significance of Left Atrium Dimension and Pulmonary 
Veins Flow Parameters for the Detection of Severe 
Diastolic Dysfunction 
Karina A. Wierzbowska, Jaroslaw Drozdz, Maria Krzeminska-Pakula, Jaroslaw 
Kasprzak, Medical University of L6dz, Lcdz, Poland 
Background: Since the occurrence of pseudonormalization assessment of diastolic func- 
tion (DF) limited to mitral inflow pattern is often difficult. The routine incorporation of other 
classic echocardiographic parameters can be of great value for correct diagnosis. We 
aimed to compare left atrium (LA) dimension and pulmonary veins flow (PVF) between 
patients (pts) with normal and pseudonormal or restrictive mitral inflow pattern and 
assess their diagnostic value for detection of severely impaired DF. Methods: Among 60 
patient after myocardial infarction examined by transthoracic echocardiography with 
assessment of diastolic function we selected 20 pts with pseudonormal or restrictive 
mitral inflow pattern, (mean age 57.li11.9, 18 male) and compared them with demo- 
graphically paired controls (20 healthy persons, mean age 56.6*9.9, 18 male). PVF was 
recorded by pulsed wave Doppler in right upper pulmonary vein. Sensitivity, specificity, 
positive predictive value, negative predictive value and accuracy were calculated for 
LAb4.2 cm, atrial reversal velocity (Ar vel)>35 cm/s. difference between duration of PV 
atrial flow and mitral atrial flow (AA+30 ms and S/D ratio <I. Results: In group with 
severely impaired DF LA was distinctly larger: 4.7kO.4 vs 3.8kO.4 cm; p<O.OOl, diastolic 
PVF (D): 0.58iO.2 vs 0.43iO.l m/s; p =0.005, and atrial reversal duration (Art): 181*28 
vs 130+17 ms significantly greater, systolic PVF (S) and systolic to diastolic ratio (S/D) 
diminished: 0.37iO.l vs 0.58rO.l m/s; p<O.OOl and 0.7tO.3 vs 1.4+0.3; ~4.2 cm sensitiv- 
Ity, specificity, positive predictive value, negative predictive value and accuracy were: 95, 
90, 91, 95, 93% respectively. For Ar vel>35 cm/s, (A4At)>30 ms end S/D<1 these values 
were: 50,85,77,63.63%, 70,100,100,77,85% and 85, 85, 85, 85, 85% respectively. 
Conclusions: LA dimension and PVF parameters are useful in detection of severely 
impaired DF and may have potential in differentiation between normal and pseudonor- 
malized pattern. Cutoff values above 4.2 cm for LA, 35 cm/s for Ar vel, S/D below 1 and 
duration of Art longer than 30 ms in comparison with mitral atrial flow showed very high 
specificity for diagnosis of ?.evere diastolic dysfunction. 
1136-80 Long-Term Follow-Up on the Morbidity and Mortality of 
Patients Hospitalized for Heart Failure With a Normal 
Ejection Fraction 
Marc Klaoholz, Niklta Varshneya. El~ezer Hernandez, Radha Voletl, Sanjay Bhargava, 
Viiavasree Kudithirxrdi. .&heed Tai. Rakesh Gwta. Gunawardena Ratnasiri. Khashavar 
Sehiat, Morcos H&ah, John A. Ambrose, Joyce Burcham, Thierry LeJemtel, St. 
Vincent’s Catholic Medical Center, New York, NY 
Background: Patients hospitalized for heart failure (HF) with a normal left ventricular 
ejection fraction (LVEF) are predominantly elderly women with a history of hypertension, 
LVH, diabetes and coronary artery disease. The long term outcomes of these patients 
after hospitalization are less well defined. 
Methods: Patients hospitalized for decompensated HF as evidenced by pulmonary con- 
gestion on admitting chest xray and volume overload on physical exam in the presence 
of a normal LVEF were eligible. Patlents who survived the index admission were pro- 
spectively followed and data on recurrent hospitalization and death were collected. 
Results: 193 patients (139 women, 54 men) were followed for a mean of 1.8 years. The 
mean age was 71.7 years. 46% had coronary artery disease and 45% were diabetic. 
80% of patients had symptoms at baseline consistent with NYHA functional class 11-111 
(10% class I, 10% class IV). 64 deaths occurred with an annualized mortality of 18.2%. 
The annualized re-hospitalization rate was 79% (graph). 
Conclusion: Patients hospitalized for HF with a normal LVEF have significant long term 
morbidity and mortality. The mortality rate exceeds that generally reported in NYHA class 
II-ill systolic dysfunction HF patients and probably reflects the presence of significant co- 
morbidities in these patients Including advanced age. The annualized re-hospitalization 
